The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Physiological Society
2016
|
| _version_ | 1797112027882192896 |
|---|---|
| author | Slingo, M Cole, M Carr, C Curtis, M Dodd, M Giles, L Heather, L Tyler, D Clarke, K Robbins, P |
| author_facet | Slingo, M Cole, M Carr, C Curtis, M Dodd, M Giles, L Heather, L Tyler, D Clarke, K Robbins, P |
| author_sort | Slingo, M |
| collection | OXFORD |
| description | Hypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse model of Chuvash polycythemia (CP), a rare genetic disorder which modestly increases expression of HIF target genes in normoxia, to understand what these effects might be within the heart. An integrated in and ex vivo approach was employed. In comparison to wild-type controls, CP mice had evidence (using in vivo MRI) of pulmonary hypertension, right ventricular hypertrophy, and increased left ventricular ejection fraction. Glycolytic flux (measured using (3)H glucose) in the isolated, contracting, perfused CP heart was 1.8-fold higher. Net lactate efflux was 1.5-fold higher. Furthermore, in vivo (13)C magnetic resonance spectroscopy (MRS) of hyperpolarized (13)C1 pyruvate revealed a 2-fold increase in real-time flux through lactate dehydrogenase in the CP hearts, and a 1.6-fold increase through pyruvate dehydrogenase. (31)P MRS of perfused CP hearts under increased workload (isoproterenol infusion) demonstrated increased depletion of phosphocreatine relative to ATP. Intriguingly, no changes in cardiac gene expression were detected. In summary, a modest systemic dysregulation of the HIF pathway resulted in clear alterations in cardiac metabolism and energetics. However, in contrast to studies generating high HIF levels within the heart, the CP mice showed neither the predicted changes in gene expression nor any degree of LV impairment. We conclude that the effects of manipulating HIF on the heart are dose-dependent. |
| first_indexed | 2024-03-07T08:18:34Z |
| format | Journal article |
| id | oxford-uuid:5541ccac-b63c-434d-9007-5d4226c1cc88 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T08:18:34Z |
| publishDate | 2016 |
| publisher | American Physiological Society |
| record_format | dspace |
| spelling | oxford-uuid:5541ccac-b63c-434d-9007-5d4226c1cc882024-01-18T15:40:59ZThe von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolismJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5541ccac-b63c-434d-9007-5d4226c1cc88EnglishSymplectic Elements at OxfordAmerican Physiological Society2016Slingo, MCole, MCarr, CCurtis, MDodd, MGiles, LHeather, LTyler, DClarke, KRobbins, PHypoxia-inducible factor (HIF) appears to function as a global master regulator of cellular and systemic responses to hypoxia. HIF-pathway manipulation is of therapeutic interest, however global, systemic upregulation of HIF may have as yet unknown effects on multiple processes. We utilized a mouse model of Chuvash polycythemia (CP), a rare genetic disorder which modestly increases expression of HIF target genes in normoxia, to understand what these effects might be within the heart. An integrated in and ex vivo approach was employed. In comparison to wild-type controls, CP mice had evidence (using in vivo MRI) of pulmonary hypertension, right ventricular hypertrophy, and increased left ventricular ejection fraction. Glycolytic flux (measured using (3)H glucose) in the isolated, contracting, perfused CP heart was 1.8-fold higher. Net lactate efflux was 1.5-fold higher. Furthermore, in vivo (13)C magnetic resonance spectroscopy (MRS) of hyperpolarized (13)C1 pyruvate revealed a 2-fold increase in real-time flux through lactate dehydrogenase in the CP hearts, and a 1.6-fold increase through pyruvate dehydrogenase. (31)P MRS of perfused CP hearts under increased workload (isoproterenol infusion) demonstrated increased depletion of phosphocreatine relative to ATP. Intriguingly, no changes in cardiac gene expression were detected. In summary, a modest systemic dysregulation of the HIF pathway resulted in clear alterations in cardiac metabolism and energetics. However, in contrast to studies generating high HIF levels within the heart, the CP mice showed neither the predicted changes in gene expression nor any degree of LV impairment. We conclude that the effects of manipulating HIF on the heart are dose-dependent. |
| spellingShingle | Slingo, M Cole, M Carr, C Curtis, M Dodd, M Giles, L Heather, L Tyler, D Clarke, K Robbins, P The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title_full | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title_fullStr | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title_full_unstemmed | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title_short | The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| title_sort | von hippel lindau chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism |
| work_keys_str_mv | AT slingom thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT colem thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT carrc thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT curtism thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT doddm thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT gilesl thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT heatherl thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT tylerd thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT clarkek thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT robbinsp thevonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT slingom vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT colem vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT carrc vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT curtism vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT doddm vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT gilesl vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT heatherl vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT tylerd vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT clarkek vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism AT robbinsp vonhippellindauchuvashmutationinmicealterscardiacsubstrateandhighenergyphosphatemetabolism |